omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
9:00 am Thursday, February 5 Proteomics – Technology 2 Room B1<br />
Wei-Wei Zhang<br />
GenWay Biotech, Inc.<br />
10130 Sorrento Valley Road, Suite C<br />
San Diego, Cali<strong>for</strong>nia 92121<br />
wzhang@genwaybio.com<br />
Polyclonal Gene-Specific IgY Antibodies <strong>for</strong> Proteomics <strong>and</strong> Abundant Plasma<br />
Protein Depletion<br />
91<br />
Co-Author(s)<br />
Xiangming Fang<br />
Jerry Feitelson<br />
Lei Huang<br />
Kena Wang<br />
Polyclonal IgY antibodies are produced based upon gene in<strong>for</strong>mation via immunizing chickens with gene<br />
expression vectors <strong>and</strong>/or purified protein antigens. Antibodies produced by this approach have high specificity<br />
<strong>and</strong> typically bind to a single gene product. Gene-specific IgY antibodies have several distinct advantages over<br />
conventional IgG antibodies due to their higher surface stability, lower cross-reactivity, stronger avidity, <strong>and</strong><br />
higher binding capacity. Besides being useful in conventional immunoassays, IgY antibodies have demonstrated<br />
applicability <strong>for</strong> multiplex assays. In the Luminex-100 System <strong>and</strong> on Ciphergen’s ProteinChip, detection<br />
sensitivities reached 10 pg/ml <strong>and</strong> 40 fg/ml, respectively. To make detection of low-abundant proteins more<br />
effective <strong>and</strong> to facilitate human plasma proteomics studies, IgY antibodies are covalently conjugated to polymeric<br />
beads via Fc region <strong>for</strong> selectively removing abundant plasma proteins, such as albumin, IgG, transferrin, <strong>and</strong><br />
fibrinogen. After short incubation of IgY beads with serum or plasma samples, target proteins are specifically<br />
bound to the IgY beads at an approximately 1:1 molar ratio. The flow-through samples can be used <strong>for</strong> proteomics<br />
analysis <strong>and</strong> <strong>for</strong> developing clinical diagnosis markers. This allows <strong>for</strong> highly sensitive analysis of rare proteins in<br />
blood samples using 2D gels <strong>and</strong> mass spectrometry. Also, polyclonal IgY against human serum albumin is shown<br />
to be capable of effectively removing the albumins from the serum samples of mouse, rat, pig, <strong>and</strong> goat. This<br />
cross-species binding of albumin cannot be accomplished by using IgG against the same antigen, indicating the<br />
unique <strong>and</strong> important feature of IgY in application <strong>for</strong> proteomics studies.<br />
9:30 am Thursday, February 5 Proteomics – Technology 2 Room B1<br />
Dhaval N. Gosalia<br />
University of Pennsylvania<br />
1150 Vagelos Labs<br />
3340 Smith Walk<br />
Philadelphia, Pennsylvania 19104<br />
dhavalg@seas.upenn.edu<br />
Protease Substrate Profiling Using Microarrays<br />
Co-Author(s)<br />
Scott L. Diamond,<br />
Cleo M. Salisbury,<br />
Jonathan A. Ellman<br />
University of Cali<strong>for</strong>nia, Berkeley<br />
We developed a novel technique <strong>for</strong> microarray-based enzymatic assays <strong>for</strong> biological reactions at nanoliter<br />
volumes. The technique allows <strong>for</strong> rapid determination of protease substrate specificity with minimal sample<br />
usage. A peptidyl coumarin library of fluorogenic protease substrates, ACC-P1-P2-P3-P4-Ac was synthesized in<br />
parallel using st<strong>and</strong>ard Fmoc-based solid-phase synthesis techniques. The amino acids at P1 <strong>and</strong> P4 were held<br />
constant with P1=lysine <strong>and</strong> P4=alanine, <strong>and</strong> all combinations of proteinogenic amino acids (except cysteine)<br />
were used at the P2 <strong>and</strong> P3 positions, <strong>for</strong> a total of 361 compounds. Purity of the library was demonstrated<br />
by HPLC-MS, <strong>and</strong> the substrates were reconstituted in DMSO to a concentration of 10 mM. The library, along<br />
with appropriate controls, was further diluted to 1 mM concentration with 50% (v/v) glycerol <strong>and</strong> microarrayed<br />
on a st<strong>and</strong>ard microscope slide with a density of 400 spot/cm². The microarrayed library was treated with the<br />
serine protease human thrombin <strong>and</strong> then scanned. The chip demonstrated that thrombin had an extremely high<br />
specificity <strong>for</strong> proline at position P2. The remaining amino acids at the P2 position produced essentially no signal<br />
above background. Definite specificities were observed <strong>for</strong> amino acids at the P3 position with Q, V, W, Y, R<br />
resulting in the fastest cleavage <strong>and</strong> P3=D, P, A, H, E resulting in the slowest cleavage. The microarray specificities<br />
agreed with previously published results, demonstrating that the technique provides accurate substrate specificity<br />
in<strong>for</strong>mation. This study indicates that protease substrate profiling can be done in this microarray <strong>for</strong>mat.<br />
PODIUM ABSTRACTS